Thermolabile variant of 5, 10-methylenetetrahydrofolate reductaseassociated with low red-cell folates: implications for folate intake recommendations
- 1 May 1997
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 349 (9065), 1591-1593
- https://doi.org/10.1016/s0140-6736(96)12049-3
Abstract
No abstract availableFunding Information
- Irish Heart Foundation
- National Institute of Child Health and Human Development
- Health Research Board
This publication has 13 references indexed in Scilit:
- Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine ConcentrationsCirculation, 1996
- Folate Levels and Neural Tube DefectsJAMA, 1995
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease.Circulation, 1993
- Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's diseaseThe Lancet, 1992
- Microbiological assay on microtitre plates of folate in serum and red cells.Journal of Clinical Pathology, 1992
- Homocystinuria due to 5,10‐methylenetetra‐hydrofolate reductase deficiency revealed by stroke in adult siblingsNeurology, 1991
- Comparison of Folic Acid Coenzyme Distribution Patterns in Patients with Methylenetetrahydrofolate Reductase and Methionine Synthetase DeficienciesPediatric Research, 1985
- Folate Distribution in Cultured Human CellsJCI Insight, 1979